BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form – ET HealthWorld | Pharma
![BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form – ET HealthWorld | Pharma BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106519714,imgsize-13300,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/bdr-pharmaceuticals-introduces-prostate-cancer-treatment-drug-in-oral-solution-form.jpg)
New Delhi: BDR Pharmaceuticals on Tuesday said it has introduced Enzalutamide oral solution for treatment of prostate cancer, claiming to ...
Read more
US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery – ET HealthWorld | Pharma
![US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery – ET HealthWorld | Pharma US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106515457,imgsize-15034,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/us-fda-approvals-bounce-back-in-2023-sparking-hopes-of-a-biotech-recovery.jpg)
Bengaluru: The US Food and Drug Administration approved nearly 50 per cent more novel drugs in 2023 than in 2022, ...
Read more
Glenmark launches biosimilar of anti-diabetic drug Liraglutide in India – ET HealthWorld | Pharma
![Glenmark launches biosimilar of anti-diabetic drug Liraglutide in India – ET HealthWorld | Pharma Glenmark launches biosimilar of anti-diabetic drug Liraglutide in India – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106509034,imgsize-12156,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/glenmark-launches-biosimilar-of-anti-diabetic-drug-liraglutide-in-india.jpg)
Mumbai: Glenmark Pharmaceuticals Ltd has launched a biosimilar of the anti-diabetic drug Liraglutide for the first time in India, The ...
Read more
Novartis signs gene therapy deal with Voyager for $100 mln upfront – ET HealthWorld | Pharma
![Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106504659,imgsize-12854,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/novartis-signs-gene-therapy-deal-with-voyager-for-100-mln-upfront.jpg)
Bangalore: Voyager Therapeutics said on Tuesday Swiss-based drugmaker novartis would pay $100 million upfront as part of a licensing deal ...
Read more
Novartis signs gene therapy deal with Voyager for $100 mln upfront – ET HealthWorld | Pharma
![Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106504659,imgsize-12854,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/novartis-signs-gene-therapy-deal-with-voyager-for-100-mln-upfront.jpg)
Bangalore: Voyager Therapeutics said on Tuesday Swiss-based drugmaker novartis would pay $100 million upfront as part of a licensing deal ...
Read more
New weight loss drugs are out of reach for millions of older Americans because Medicare won’t pay – ET HealthWorld | Pharma
![New weight loss drugs are out of reach for millions of older Americans because Medicare won’t pay – ET HealthWorld | Pharma New weight loss drugs are out of reach for millions of older Americans because Medicare won’t pay – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106369775,imgsize-32542,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/new-weight-loss-drugs-are-out-of-reach-for-millions-of-older-americans-because-medicare-wont-pay.jpg)
WASHINGTON: New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out ...
Read more
Cell and gene therapy to have greatest impact on pharmaceutical industry in 2024: GlobalData – ET HealthWorld | Pharma
![Cell and gene therapy to have greatest impact on pharmaceutical industry in 2024: GlobalData – ET HealthWorld | Pharma Cell and gene therapy to have greatest impact on pharmaceutical industry in 2024: GlobalData – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106358169,imgsize-10134,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/cell-and-gene-therapy-to-have-greatest-impact-on-pharmaceutical-industry-in-2024-globaldata.jpg)
London: Healthcare industry professionals scored cell and gene therapy (CGT) as the industry trend to have the greatest impact on ...
Read more
2023 has been pivotal for JB Pharma: Nikhil Chopra – ET HealthWorld | Pharma
![2023 has been pivotal for JB Pharma: Nikhil Chopra – ET HealthWorld | Pharma 2023 has been pivotal for JB Pharma: Nikhil Chopra – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106354547,imgsize-44646,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/2023-has-been-pivotal-for-jb-pharma-nikhil-chopra.jpg)
New Delhi : Nikhil ChopraCEO & Whole Time Director, JB Pharma spoke to ETHealthworld’s Prathiba Raju about how 2023 has ...
Read more